There are going to be plenty of people who will be of the opinion that it is far-fetched to think that we could sell 10 million vials of lenz in the year following FDA approval.
I think it is harder to believe that over 105M Americans, who are not sick, would get vaccinated by products that are not FDA approved.
I'm just looking forward to a realistic outline from management in regards to anticipated demand and expected revenue. That's assuming, of course, that they haven't done that already by stating 100k doses and $10,000 treatment cost.
Market Data 
Markets 
AI
